Literature DB >> 9071946

Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?

T Sahmoud1, J Y Mary, T Sahmoud1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9071946      PMCID： PMC1027063          DOI： 10.1136/gut.40.2.284

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  14 in total

1.  Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease.

Authors:  C Brignola; P Iannone; S Pasquali; M Campieri; P Gionchetti; A Belluzzi; O Basso; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease.

Authors:  C Brignola; M Campieri; G Bazzocchi; P Farruggia; A Tragnone; G A Lanfranchi
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682

3.  Controlled trial of azathioprine in Crohn's disease.

Authors:  J M Willoughby; J Beckett; P J Kumar; A M Dawson
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

4.  National Cooperative Crohn's Disease Study: results of drug treatment.

Authors:  R W Summers; D M Switz; J T Sessions; J M Becktel; W R Best; F Kern; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

5.  Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease.

Authors:  C Prantera; F Pallone; G Brunetti; M Cottone; M Miglioli
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

6.  Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.

Authors:  A Messori; C Brignola; G Trallori; R Rampazzo; G Bardazzi; C Belloli; G d'Albasio; G De Simone; N Martini
Journal:  Am J Gastroenterol       Date:  1994-05       Impact factor: 10.864

7.  European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.

Authors:  H Malchow; K Ewe; J W Brandes; H Goebell; H Ehms; H Sommer; H Jesdinsky
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

8.  Meta-analysis of the literature or of individual patient data: is there a difference?

Authors:  L A Stewart; M K Parmar
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

9.  Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.

Authors:  D P O'Donoghue; A M Dawson; J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

10.  Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

Authors:  J P Gendre; J Y Mary; C Florent; R Modigliani; J F Colombel; J C Soulé; J P Galmiche; E Lerebours; L Descos; J M Viteau
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682
View more
  1 in total

1.  Cost-Effectiveness of Budesonide Controlled Ileal Release (CIR) Capsules as Maintenance Therapy versus No Maintenance Therapy for Ileocaecal Crohn's Disease in Sweden.

Authors:  I Noble; R Brown; A Danielsson; K Ericsson; C H Florén; P Hertzman; R Löfberg
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.